Spasticity and Motor Disorder Care
Clinical activity is centered on brain damage-related spasticity, with attention to severe involvement of the upper limbs and lower limbs.
- Severe spasticity
- Upper limb impairment
- Lower limb impairment
The research interest lies in managing movement restriction and muscle overactivity in patients affected by neurological injury.
Botulinum Toxin Therapy
The sponsor funds work involving incobotulinumtoxinA and botulinum toxin type A for neurologic muscle tone disorders.
- IncobotulinumtoxinA
- Botulinum toxin type A
- Individualized treatment
This area focuses on the clinical use of toxin-based treatment for patients whose spasticity patterns require tailored therapeutic support.
Neurological Rehabilitation
Research interest extends to rehabilitation-oriented management of neurological impairment after brain injury, with emphasis on functional limitations linked to spasticity.
- Brain injury-associated disability
- Functional limitation
- Muscle tone management
The clinical focus reflects care for patients requiring ongoing support for motor control and limb function.
